How can my daughter manage her Hodgkin lymphoma at age 27?

Question

Hello doctor,

My 27-year-old daughter has been diagnosed with stage 2B Hodgkin lymphoma after doctors discovered swollen lymph nodes in her neck and chest, along with months of drenching night sweats. She has lost 24 pounds and suffers from crushing fatigue, which we initially attributed to stress from her demanding marketing job.

Her oncologist recommends starting ABVD chemotherapy immediately, but we are devastated about the potential impact on her fertility, especially since she is getting married in eight months. She is also terrified about losing her beautiful hair right before the wedding and how treatment might affect the career she has just begun building.

The proposed treatment plan involves six months of chemotherapy, possibly followed by radiation, which feels like an eternity for someone who was otherwise young and healthy. We have read about newer immunotherapy options online and are wondering whether these could be realistic alternatives for her specific type and stage of lymphoma.

Her younger brother is deeply concerned about any genetic risks, as the two of them are only two years apart and extremely close. The doctors have reassured us that the cure rates are excellent, but the potential side effects sound overwhelming for someone just beginning adult life.

Her fiancé is trying to stay supportive, but we can see his fear and uncertainty about their future together. Could you please explain all available fertility preservation options and whether there are any less toxic clinical trials or targeted therapies appropriate for her case? We are desperate for a realistic hope that she can still have children after overcoming this nightmare.

Please advise.

Thank you.

Answer 1

Hello,

Welcome to icliniq.com.

I am truly sorry your family is going through this.

A cancer diagnosis at 27, right when life feels like it is just beginning, is deeply overwhelming. Hodgkin lymphoma at stage 2B may sound frightening, but it is one of the most curable cancers in all of oncology, with long-term survival in the ninety percent range even for advanced stages.

ABVD (Adriamycin, Bleomycin, Vinblastine, and Dacarbazine) chemotherapy is still considered the gold standard because it cures the majority of patients with the least long-term toxicity. Hair loss and fatigue are real side effects, but they are temporary, and many young patients are able to continue at least some normal life during treatment. Regarding fertility, you are right to ask early.

Before starting chemotherapy, she can see a fertility specialist to preserve eggs or embryos by ovarian stimulation and freezing. Some centers also offer ovarian tissue freezing, which can preserve hormonal function and fertility for the future. During chemotherapy, a medication called a GnRH (gonadotropin-releasing hormone) agonist may be given to temporarily put the ovaries at rest, which may reduce the risk of chemotherapy-related infertility. Many women treated with ABVD still resume normal menstrual cycles and go on to have children naturally after treatment, so hope here is very real.

About newer immunotherapy and targeted agents, drugs like Pembrolizumab and Nivolumab are approved mainly for relapsed or refractory Hodgkin lymphoma. For newly diagnosed stage 2 disease, there is no standard first-line treatment yet since ABVD cures so many patients.

Clinical trials do exist in some cancer centers, testing whether adding or substituting targeted agents can reduce long-term toxicity, so her oncologist can discuss trial availability if you want to explore that path. Her brother’s concern is understandable, but Hodgkin lymphoma is usually not strongly hereditary, and his overall risk is still low.

Please know that despite the shock and fear, this cancer is one of the few where doctors are confident about a cure, and most young women go on to live full, healthy lives, build careers, get married, and have children. You do not need to lose hope.

I hope this helps you.

Thank you.